ETFs holding AbCellera Biologics Inc. stocks
Below are funds with AbCellera Biologics Inc. stocks, sorted by market value. Equipped with price, change, and other helpful stats, they make investing in ABCL more accessible and offer more opportunities at a lower risk.
Symbol | Market value | Weight | Issuer | Management style | Focus | Expense ratio | AUM | Price | Change % | Rel Volume | NAV total return 3Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
 IBBiShares Biotechnology ETF | 6.32 M USD | 0.11% | BlackRock, Inc. | Passive | Health care | 0.44% | 5.74 B USD | 142.41 USD | +1.03% | 0.96 | +18.53% |
| IDNAiShares Genomics Immunology and Healthcare ETF | 2.64 M USD | 2.32% | BlackRock, Inc. | Passive | Theme | 0.47% | 112.14 M USD | 23.05 USD | +1.41% | 0.53 | −13.83% |
| 2B78iShares Healthcare Innovation UCITS ETF | 1.21 M USD | 0.13% | BlackRock, Inc. | Passive | Health care | 0.40% | 937.55 M USD | 6.838 EUR | +0.89% | 0.98 | −2.76% |
 00897Fubon NYSE Factset Global Genomics and Immuno Biopharma ETF | 1.05 M USD | 2.28% | Fubon Financial Holding Co., Ltd. | Passive | Theme | 1.05% | 46.82 M USD | 7.39 TWD | +2.21% | 0.14 | −7.89% |
| BTECiShares NASDAQ US Biotechnology UCITS ETF | 778.86 K USD | 0.13% | BlackRock, Inc. | Passive | Health care | 0.35% | 561.66 M USD | 7.0225 USD | +1.81% | 1.55 | +25.86% |
| BTEEiShares NASDAQ US Biotechnology UCITS ETF | 778.86 K USD | 0.13% | BlackRock, Inc. | Passive | Health care | 0.35% | 25.8 M USD | 6.993 USD | +1.85% | 0.44 | +25.85% |
 GWXSPDR S&P International Small Cap ETF | 774.95 K USD | 0.10% | State Street Corp. | Passive | Small cap | 0.40% | 781.44 M USD | 40.18 USD | +0.10% | 1.09 | +66.86% |
 ONEQFidelity Nasdaq Composite Index ETF | 662.22 K USD | 0.01% | FMR LLC | Passive | Total market | 0.21% | 8.86 B USD | 88.87 USD | +0.52% | 0.98 | +108.86% |
| AGEDiShares Ageing Population UCITS ETF | 592.7 K USD | 0.11% | BlackRock, Inc. | Passive | Total market | 0.40% | 557.16 M USD | 8.9900 USD | +0.36% | 0.51 | +51.03% |
 SBIOInvesco NASDAQ Biotech UCITS ETF | 450.8 K USD | 0.13% | Invesco Ltd. | Passive | Health care | 0.40% | 338.07 M USD | 50.14 USD | +1.81% | 0.36 | +25.82% |
 BBCVirtus LifeSci Biotech Clinical Trials ETF | 175.92 K USD | 1.00% | Virtus Investment Partners, Inc. | Passive | Health care | 0.79% | 16.67 M USD | 27.06 USD | +0.94% | 1.90 | +9.14% |
| XDNAiShares Genomics Immunology and Healthcare Index ETF Trust Units | 81.7 K USD | 2.33% | BlackRock, Inc. | Passive | Health care | 0.47% | 3.46 M USD | 33.01 CAD | +1.88% | 0.98 | −1.71% |
 203780MIRAE ASSET TIGER NASDAQ BIO ETF | 60.39 K USD | 0.13% | Mirae Asset Global Investments Co., Ltd. | Passive | Health care | 0.30% | 45.94 M USD | 24,805 KRW | +0.89% | 0.21 | +25.80% |
| IBBQInvesco Nasdaq Biotechnology ETF | 51.73 K USD | 0.14% | Invesco Ltd. | Passive | Health care | 0.19% | 36.81 M USD | 24.07 USD | +1.17% | 0.73 | +26.51% |
 BIBProShares Ultra Nasdaq Biotechnology | 50.46 K USD | 0.09% | ProShare Advisors LLC | Passive | Health care | 0.95% | 53.8 M USD | 58.35 USD | +2.27% | 1.66 | +18.09% |
 00678Capital Nasdaq Biotechnology Index ETF | 7.16 K USD | 0.09% | Qunyi Securities Investment Trust Co. Ltd. | Passive | Health care | 1.01% | 8.26 M USD | 28.58 TWD | +2.40% | 0.03 | +18.05% |